Royal Bank Of Canada Repligen Corp Transaction History

Royal Bank Of Canada

  • $479 Billion
  • Q4 2024

A detailed history of Royal Bank Of Canada transactions in Repligen Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 114,936 shares of RGEN stock, worth $17.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,936
Previous 115,955 0.88%
Holding current value
$17.3 Million
Previous $17.3 Million 4.13%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$123.41 - $160.92 $125,754 - $163,977
-1,019 Reduced 0.88%
114,936 $16.5 Million
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $568,403 - $794,075
4,745 Added 4.27%
115,955 $17.3 Million
Q2 2024

Aug 14, 2024
SELL
$120.0 - $182.95 $2.76 Million - $4.2 Million
-22,983 Reduced 17.13%
111,210 $14 Million
Q1 2024

Nov 05, 2024
BUY
$170.78 - $208.42 $3.93 Million - $4.79 Million
22,983 Added 20.67%
134,193 $24.7 Million
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $3.79 Million - $4.62 Million
22,168 Added 19.79%
134,193 $24.7 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $182,557 - $296,374
1,599 Added 1.45%
112,025 $20.1 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $92,011 - $117,026
663 Added 0.6%
110,426 $17.6 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $3.76 Million - $4.9 Million
27,148 Added 32.86%
109,763 $15.5 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $2.56 Million - $3.29 Million
16,608 Added 25.16%
82,615 $13.9 Million
Q4 2022

Feb 14, 2023
SELL
$162.42 - $220.56 $801,380 - $1.09 Million
-4,934 Reduced 6.96%
66,007 $11.2 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $773,063 - $1.23 Million
-4,819 Reduced 6.36%
70,941 $13.3 Million
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $950,434 - $1.27 Million
6,756 Added 9.79%
75,760 $12.3 Million
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $310,290 - $496,572
-1,925 Reduced 2.71%
69,004 $13 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $2.31 Million - $2.84 Million
-9,343 Reduced 11.64%
70,929 $18.8 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $1.87 Million - $3.11 Million
-9,593 Reduced 10.67%
80,272 $23.2 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $14.9 Million - $19.9 Million
89,865 New
89,865 $17.9 Million

Others Institutions Holding RGEN

# of Institutions
482
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.36B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email